Molecular Biology of the Cell click for ASCB 2010 Annual Meeting page

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBoC in Press, 10.1091/mbc.E08-05-0451 on January 21, 2009

Vol. 20, Issue 6, 1715-1727, March 15, 2009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Materials
Right arrow All Versions of this Article:
E08-05-0451v1
20/6/1715    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carvajal-Gonzalez, J. M.
Right arrow Articles by Fernandez-Salguero, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carvajal-Gonzalez, J. M.
Right arrow Articles by Fernandez-Salguero, P. M.

The Dioxin Receptor Regulates the Constitutive Expression of the Vav3 Proto-Oncogene and Modulates Cell Shape and Adhesion

Jose M. Carvajal-Gonzalez*, Sonia Mulero-Navarro*, Angel Carlos Roman*, Vincent Sauzeau{dagger}, Jaime M. Merino*, Xose R. Bustelo{dagger}, and Pedro M. Fernandez-Salguero*

*Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, 06071 Badajoz, Spain; and {dagger}Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, Campus Unamuno, 37007 Salamanca, Spain

Submitted May 2, 2008; Revised December 2, 2008; Accepted January 8, 2009
Monitoring Editor: Josephine C. Adams

The dioxin receptor (AhR) modulates cell plasticity and migration, although the signaling involved remains unknown. Here, we report a mechanism that integrates AhR into these cytoskeleton-related functions. Immortalized and mouse embryonic fibroblasts lacking AhR (AhR–/–) had increased cell area due to spread cytoplasms that reverted to wild-type morphology upon AhR re-expression. The AhR-null phenotype included increased F-actin stress fibers, depolarized focal adhesions, and enhanced spreading and adhesion. The cytoskeleton alterations of AhR–/– cells were due to down-regulation of constitutive Vav3 expression, a guanosine diphosphate/guanosine triphosphate exchange factor for Rho/Rac GTPases and a novel transcriptional target of AhR. AhR was recruited to the vav3 promoter and maintained constitutive mRNA expression in a ligand-independent manner. Consistently, AhR–/– fibroblasts had reduced Rac1 activity and increased activation of the RhoA/Rho kinase (Rock) pathway. Pharmacological inhibition of Rac1 shifted AhR+/+ fibroblasts to the null phenotype, whereas Rock inhibition changed AhR-null cells to the AhR+/+ morphology. Knockdown of vav3 transcripts by small interfering RNA induced cytoskeleton defects and changes in adhesion and spreading mimicking those of AhR-null cells. Moreover, vav3–/– MEFs, as AhR–/– mouse embryonic fibroblasts, had increased cell area and enhanced stress fibers. By modulating Vav3-dependent signaling, AhR could regulate cell shape, adhesion, and migration under physiological conditions and, perhaps, in certain pathological states.


This was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-05-0451) on January 21, 2009.

Address correspondence to: Pedro M. Fernandez-Salguero (pmfersal{at}unex.es)

Abbreviations used: AhR, aryl hydrocarbon (dioxin) receptor; FGM, immortalized mouse fibroblasts; FN, fibronectin; GAP, GTPase-activating protein; GEF, guanosine diphosphate/guanosine triphosphate exchange factor; MEF, mouse embryonic fibroblast; YFP, yellow fluorescent protein.




This article has been cited by other articles:


Home page
Toxicol SciHome page
A. Ambolet-Camoit, L. C. Bui, S. Pierre, A. Chevallier, A. Marchand, X. Coumoul, M. Garlatti, K. Andreau, R. Barouki, and M. Aggerbeck
2,3,7,8-Tetrachlorodibenzo-p-Dioxin Counteracts the p53 Response to a Genotoxicant by Upregulating Expression of the Metastasis Marker AGR2 in the Hepatocarcinoma Cell Line HepG2
Toxicol. Sci., June 1, 2010; 115(2): 501 - 512.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. I. Fraser, C. A. Dendrou, B. Healy, D. B. Rainbow, S. Howlett, L. J. Smink, S. Gregory, C. A. Steward, J. A. Todd, L. B. Peterson, et al.
Nonobese Diabetic Congenic Strain Analysis of Autoimmune Diabetes Reveals Genetic Complexity of the Idd18 Locus and Identifies Vav3 as a Candidate Gene
J. Immunol., May 1, 2010; 184(9): 5075 - 5084.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Roman, J. M. Carvajal-Gonzalez, E. M. Rico-Leo, and P. M. Fernandez-Salguero
Dioxin Receptor Deficiency Impairs Angiogenesis by a Mechanism Involving VEGF-A Depletion in the Endothelium and Transforming Growth Factor-{beta} Overexpression in the Stroma
J. Biol. Chem., September 11, 2009; 284(37): 25135 - 25148.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2009 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.